|
MYST2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71149999994569E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.99280999999552E-05 |
| Normal-vs-Stage2 |
1.287960E-02 |
| Normal-vs-Stage3 |
6.000500E-04 |
| Normal-vs-Stage4 |
2.173200E-04 |
| Stage1-vs-Stage2 |
8.409000E-01 |
| Stage1-vs-Stage3 |
8.339400E-01 |
| Stage1-vs-Stage4 |
4.063400E-01 |
| Stage2-vs-Stage3 |
9.331800E-01 |
| Stage2-vs-Stage4 |
4.465400E-01 |
| Stage3-vs-Stage4 |
3.882000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.87571999999969E-05 |
| Normal-vs-AfricanAmerican |
1.62266000000022E-05 |
| Normal-vs-Asian |
2.563400E-03 |
| Caucasian-vs-AfricanAmerican |
4.556800E-01 |
| Caucasian-vs-Asian |
5.935000E-01 |
| AfricanAmerican-vs-Asian |
6.782400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.28460000309505E-08 |
| Normal-vs-Female |
1.793760E-01 |
| Male-vs-Female |
5.498300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.371950E-02 |
| Normal-vs-Extreme_Weight |
1.22300000005016E-06 |
| Normal-vs-Obese |
2.820200E-04 |
| Normal-vs-Extreme_Obese |
1.596990E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.908800E-01 |
| Normal_Weight-vs-Obese |
9.032200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.741400E-01 |
| Extreme_Weight-vs-Obese |
2.312000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.753400E-01 |
| Obese-vs-Extreme_Obese |
3.067200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.901000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.381000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.51310000084948E-08 |
| Normal-vs-Age(81-100Yrs) |
2.80909999994527E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.539600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.557700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.797900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.977000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.103660E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.028400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.57220000005254E-06 |
| Normal-VS-Type2 PRCC |
2.4647999999905E-06 |
| Normal-VS-KIRP CIMP |
1.913190E-01 |
| Normal-VS-Unclassified PRCC |
6.056300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.926400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.208800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.298200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.102200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.011770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.433200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.24470000032007E-07 |
| Normal-vs-N1 |
1.279630E-01 |
| Normal-vs-N2 |
2.998200E-01 |
| N0-vs-N1 |
1.375360E-01 |
| N0-vs-N2 |
2.023200E-01 |
| N1-vs-N2 |
9.174600E-01 |
|
|
